CLINICAL_TRIALS
trial_result
· 2021-09-29
Clinical Trial Update: Anisodamine Critically Ill SeptIc Shock [Phase 1, Phase 2]
Summary
Phase 1/2 trial update for anisodamine in critically ill patients with septic shock; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jinhua Central Hospital | Conditions: Septic Shock | Phase 1, Phase 2 | Status: COMPLETED